ArticleThe British journal of dermatology2022
Cost-effectiveness of a policy-based intervention to reduce melanoma and other skin cancers associated with indoor tanning.
Article in The British journal of dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- New Primary and Secondary Prevention Measures for Cutaneous Melanoma: A Systematic Review.Cancer reports (Hoboken, N.J.) · 2026Pooled it
- The Cost-Effectiveness of Primary Prevention Interventions for Skin Cancer: An Updated Systematic Review.Applied health economics and health policy · 2024Pooled it
- Reasons for using indoor tanning devices: A systematic review of qualitative evidence.British journal of health psychology · 2023Pooled it
- Tans, Bans, and Sedans: How Distance from Tanning Beds May Save Lives.The Journal of investigative dermatology · 2025Article
- Analysis of facilitators of and barriers to enactment of state regulation of indoor tanning by minors.Translational behavioral medicine · 2025Article
- Artificial Intelligence-Driven Skin Aging Simulation as a Novel Skin Cancer Prevention.Dermatology (Basel, Switzerland) · 2025Observational
- Global, regional, national prevalence, mortality, and disability-adjusted life-years of cutaneous squamous cell carcinoma and trend analysis from 1990 to 2021 and prediction to 2045.Frontiers in oncology · 2025Article
- Cost-effectiveness analysis and return on investment of SunSmart Western Australia to prevent skin cancer.Health promotion international · 2024Article
- Skin Cancer Prevention across the G7, Australia and New Zealand: A Review of Legislation and Guidelines.Current oncology (Toronto, Ont.) · 2023Review
- Educational level-dependent melanoma awareness in a high-risk population in Switzerland.Frontiers in oncology · 2023Article
- An Epidemiological Update on Indoor Tanning and the Risk of Skin Cancers.Current oncology (Toronto, Ont.) · 2022Review
- A 10-Year Review of Sunburn Injuries Presenting to the Manchester Adult and Paediatric Specialist Burn Services.European burn journal · 2022Article
- Experience from an outright ban of commercial sunbeds in the Australian context.The British journal of dermatology · 2022Article
- A Method for Estimating Resource Use and Costs when Empirical Data Are Unavailable: Expert Elicitation Study Using the Example of Melanoma.MDM policy & practiceArticle
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
9 authors.
Funding
Abstract
backgroundThe use of indoor tanning devices causes melanoma and other skin cancers with resulting morbidity, mortality and increased healthcare costs. Policymakers require robust economic evidence to inform decisions about a possible ban of such devices to mitigate these burdens.
objectivesTo assess the health costs and consequences of introducing a policy-based intervention across England to ban commercial indoor tanning with an accompanying public information campaign.
methodsA cost-effectiveness analysis, adopting a healthcare system perspective, was conducted using a decision model to track a national cohort of 18-year-olds over a lifetime time horizon. A nationwide ban on commercial indoor tanning combined with a public information campaign (the policy-based intervention) was compared with the status quo of availability of commercial indoor tanning. The expected costs (currency, GBP; price year, 2019) and quality-adjusted life-years (QALYs) were calculated. Net monetary benefit (NMB) (net benefit measured in cost compared with an accepted threshold) and net health benefit (NHB) (net gain in QALYs compared with an accepted threshold) of implementation were calculated. A probabilistic sensitivity analysis was used to calculate the probability that the intervention was cost-effective.
resultsCompared with the current situation, a ban on commercial indoor tanning combined with a public information campaign would result in 1206 avoided cases of melanoma, 207 fewer melanoma deaths and 3987 averted cases of keratinocyte cancers over the lifetime of all 18-year-olds (n = 618 873) living in England in 2019. An additional 497 QALYs would be realized along with healthcare cost-savings of £697 858. This intervention would result in an NMB of £10.6m and an NHB of 530 QALYS. Multiple sensitivity analyses confirmed the robustness of the findings. At a cost-effectiveness threshold of £20 000, there is a 99% likelihood of this policy-based intervention being cost-effective.
conclusionsThe implementation of a ban on commercial indoor tanning across England with an accompanying public information campaign would be an effective use of healthcare resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.